Skip to main content
. 2022 Jan 13;12(1):127. doi: 10.3390/biom12010127

Figure 1.

Figure 1

A model showing the pathways of EBV-mediated c-Myc activation in Burkitt’s lymphoma. EBNA-2 interacts with albumin D box-binding proteins (DBPs) to activate the transcription of c-Myc. Increased production of c-Myc results in the activation of the c-Myc-targeted gene to increase cell proliferation. EBV BART miRNA inhibits MAX interactor 1 (MXI1), which is known to repress the activity of c-Myc.